title: Current and Future Medical Treatment of Obesity.
abstract: Obesity is a major health crisis resulting in comorbidities such as hypertension, type 2 diabetes, and obstructive sleep apnea. The need for safe and efficacious drugs to help assist with weight loss and reduce cardiometabolic risk factors is great. With several FDA-approved drugs on the market, there is still a great need to develop long-term obesity treatments or noninvasive oral agents to help assist individuals with obesity when used in conjunction with lifestyle modifications.
authors.affiliation: Comprehensive Weight Control Center, Division of Endocrinology, Diabetes, and Metabolism, Weill Cornell Medical College, 1165 York Avenue, New York, NY 10021, USA.
authors.forename: Devika
authors.initials: D
authors.lastname: Umashanker
authors.affiliation: Comprehensive Weight Control Center, Division of Endocrinology, Diabetes, and Metabolism, Weill Cornell Medical College, 1165 York Avenue, New York, NY 10021, USA.
authors.forename: Leon I
authors.initials: LI
authors.lastname: Igel
authors.affiliation: Comprehensive Weight Control Center, Division of Endocrinology, Diabetes, and Metabolism, Weill Cornell Medical College, 1165 York Avenue, New York, NY 10021, USA.
authors.forename: Rekha B
authors.initials: RB
authors.lastname: Kumar
authors.affiliation: Comprehensive Weight Control Center, Division of Endocrinology, Diabetes, and Metabolism, Weill Cornell Medical College, 1165 York Avenue, New York, NY 10021, USA. Electronic address: ljaronne@mail.med.cornell.edu.
authors.forename: Louis J
authors.initials: LJ
authors.lastname: Aronne
mesh_terms: D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D052938:Bariatric Medicine / Q000639:trends*; D006801:Humans; D009765:Obesity / Q000188:drug therapy*; D014481:United States; D015431:Weight Loss / Q000187:drug effects
chemical_list: D019440:Anti-Obesity Agents
keywords: Obesity; Pharmacotherapy; Weight management